iDtheinvestordatabase
Home / Directory / Antler
Active: new deal Aug 2026 Verified 4 Nov 2026

Antler

Early-stage investor that backs founders from inception through cohort programs, with offices across Asia Pacific, Europe, the Americas and the Middle East and Africa.

Type
Accelerator
Location
New York, New York, United States
Stages
Pre-seed, Seed, Series A, Series B, Growth
Backs
B2B software
Sectors
AI, Healthtech and life sciences, Biotech, Consumer, Fintech, Climate and cleantech
Fund size / AUM
$89.8M Antler US Fund II-A (Form D amount sold, 2023)
Latest fund or filing
7 Aug 2026
Portfolio mix
B2B software 55%; Biotech and pharma 10%; Climate and energy 10%; Deep tech 7%; Consumer apps 7%; Hardware 3%; Fintech 3%; Consumer products 3% (n=29, 2023 to 2026)
UK office
London

Fund filings (SEC Form D)

Latest fund on file
Antler Special Opportunities Fund III
Filed
7 Aug 2026 (new notice)
Fund size
$8M (total offering)
Fund vehicles filed in the last 12 months
3 (includes feeder and parallel vehicles)

See this fund's filings on SEC EDGAR

Contacts on file

For Antler, the paid file holds: 8 named decision-makers with roles; how to pitch (the route the firm publishes); LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

3SquareAccretion BioAirShelfAiry DigitalABIVO

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 102 lists

Series B climate tech investors in the US (27)Series B investors in New York (29)Biotech investors in New York (29)Series B consumer investors in the US (29)Startup accelerators in the US (30)Series B biotech investors in the US (34)Growth-stage climate tech investors in the US (34)Climate tech investors in New York (40)Growth-stage biotech investors in the US (44)Series A investors in New York (49)Growth-stage investors in New York (57)Series B consumer investors (59)Consumer investors in New York (59)Series B fintech investors in the US (59)Series A biotech investors in the US (59)Series A climate tech investors in the US (60)Growth-stage consumer investors in the US (60)International investors with a UK office (67)Startup accelerators (69)Series B healthtech investors in the US (69)Series B biotech investors (73)Series A consumer investors in the US (80)Pre-seed biotech investors in the US (81)Pre-seed investors in New York (82)Pre-seed climate tech investors in the US (84)Growth-stage fintech investors in the US (97)Series B climate tech investors (98)Fintech investors in New York (98)Healthtech investors in New York (100)Pre-seed consumer investors in the US (104)Series B SaaS investors in the US (108)Growth-stage biotech investors (109)Growth-stage healthtech investors in the US (121)Growth-stage consumer investors (124)Series B AI investors in the US (126)Series B fintech investors (127)Seed investors in New York (128)SaaS investors in New York (138)Series A fintech investors in the US (145)Pre-seed biotech investors (148)Series A biotech investors (153)Series A consumer investors (154)AI investors in New York (159)Seed biotech investors in the US (159)Series B healthtech investors (160)Pre-seed consumer investors (162)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Seed climate tech investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)Pre-seed fintech investors in the US (187)Growth-stage climate tech investors (189)Series B SaaS investors (196)Series B AI investors (204)Growth-stage fintech investors (214)Seed consumer investors in the US (216)Pre-seed healthtech investors in the US (225)Pre-seed climate tech investors (230)Series A SaaS investors in the US (256)Series A climate tech investors (263)Series A AI investors in the US (280)Growth-stage investors in the US (288)Series A fintech investors (294)Growth-stage AI investors (295)Seed biotech investors (300)Growth-stage healthtech investors (316)Pre-seed fintech investors (323)Seed consumer investors (331)Series B investors (339)Growth-stage SaaS investors (344)Seed fintech investors in the US (349)Pre-seed SaaS investors in the US (367)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed AI investors in the US (403)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)Seed climate tech investors (458)Series A SaaS investors (475)Biotech investors (484)Series A AI investors (500)Consumer investors (512)Pre-seed investors in the US (549)Pre-seed SaaS investors (562)Seed fintech investors (584)Pre-seed AI investors (633)Climate tech investors (660)Seed SaaS investors in the US (666)Growth-stage investors (705)Seed AI investors in the US (724)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Pre-seed investors (988)Seed SaaS investors (1,010)Seed investors in the US (1,043)Seed AI investors (1,082)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Seed investors (1,892)